Share Twitter LinkedIn Facebook Email Swaminathan P. Iyer, MD, Professor, Department of Lymphoma and Myeloma, Division of Cancer Medicine Division, MD Anderson Cancer Center, discusses Outcomes Of The ECHELON-2 Study. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com
2024 Update on Lymphoma Treatment: Navigating the Latest Advances – Elizabeth Brem, MD [38 Slides] Hodgkin Lymphoma 4 Mins Read
FDA Grants Accelerated Approval to Zanubrutinib (Brukinsa) for Relapsed or Refractory Follicular Lymphoma Lymphoma 2 Mins Read
FDA Grants Priority Review of Epcoritamab (EPKINLY): A Significant Step in Lymphoma Treatment [VIDEO EXCLUSIVE] Lymphoma 3 Mins Read